This would be a specific component of Roche's more general April announcement.*
From WTHR Television 13:
The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.
Roche will be investing $550 million to expand its diagnostics site in Indianapolis.
The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system. Indianapolis serves as the North American headquarters for Roche.
A continuous glucose monitor tracks a person's glucose in real time and is a beneficial tool for people with diabetes....
....MUCH MORE
Previously:
April 22 - "Swiss pharmaceuticals company Roche announces $50B investment in US over next 5 years"
